IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
7
Neutral
4
Bullish
3
Bearish
16
Neutral
4
Bullish
26
Bearish
9
Neutral
0
Bullish
23
Upcoming Result Date: Nov 09, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Virinchi Ltd (VIRINCHI) is currently trading at 14.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Virinchi Limited is an India-headquartered Financial Technology and Healthcare company operating SaaS products, IT/IDC services and hospitals; it maintains development centres in Hyderabad, an onshore facility in New Jersey and an IDC in Santa Clara, while owning healthcare facilities and fintech IP such as the vCard payments and niche financial services software. FY26 consolidated revenue was Rs. 286.13 crore with a negative PAT of Rs. 27.39 crore, where standalone revenues rose nearly 20% led by SaaS but consolidated profitability was hit by a one-time receivable write-off of Rs. 8.43 crore and higher administrative expenses, materially compressing margins for the quarter and year. The SaaS franchise delivered +15.4% YoY revenue growth to Rs. 153.94 crore in FY26, with two recently acquired clients (Check ’n Go and MoneyTree) achieving stable recurring run-rates, suggesting improving revenue quality even as quarterly EBIT was distorted by the bad-debt write-off. IDC & IT Services saw a sharp revenue mix shift due to a stricter U.S. visa regime; onshore high-margin work fell, billing rates compressed and the company is executing a deliberate transition to offshore delivery to preserve client continuity and protect margins, materially changing service mix and near-term profitability. Healthcare revenues declined in FY26 but operational metrics improved slightly; a new senior management team for the flagship hospital plus promoter infusion and a 49% stake acquisition in the healthcare subsidiary position Virinchi Limited to attempt a turnaround and restore structural profit growth in FY27.
Over the past 52 weeks, Virinchi Ltd has traded between a low of ₹11.80 and a high of ₹27.64. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Virinchi Ltd has a market capitalization of approximately 162.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Virinchi Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -5.45 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 162.86 Cr, Virinchi Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Virinchi Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Virinchi Ltd is -5.45. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Virinchi Limited is an India-headquartered Financial Technology and Healthcare company operating SaaS products, IT/IDC services and hospitals; it maintains development centres in Hyderabad, an onshore facility in New Jersey and an IDC in Santa Clara, while owning healthcare facilities and fintech IP such as the vCard payments and niche financial services software.
FY26 consolidated revenue was Rs. 286.13 crore with a negative PAT of Rs. 27.39 crore, where standalone revenues rose nearly 20% led by SaaS but consolidated profitability was hit by a one-time receivable write-off of Rs. 8.43 crore and higher administrative expenses, materially compressing margins for the quarter and year.
The SaaS franchise delivered +15.4% YoY revenue growth to Rs. 153.94 crore in FY26, with two recently acquired clients (Check ’n Go and MoneyTree) achieving stable recurring run-rates, suggesting improving revenue quality even as quarterly EBIT was distorted by the bad-debt write-off.
IDC & IT Services saw a sharp revenue mix shift due to a stricter U.S. visa regime; onshore high-margin work fell, billing rates compressed and the company is executing a deliberate transition to offshore delivery to preserve client continuity and protect margins, materially changing service mix and near-term profitability.
Healthcare revenues declined in FY26 but operational metrics improved slightly; a new senior management team for the flagship hospital plus promoter infusion and a 49% stake acquisition in the healthcare subsidiary position Virinchi Limited to attempt a turnaround and restore structural profit growth in FY27.
IT - Software
Software Products
163 Cr
High Risk
-5.5
18.8
—
0.3
27.64
11.80
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
36.29 | 187 Cr | -24.84 | 0.61 | 0.00 | -0.60 | -1.08 | -1.68 | ||
14.25 | 163 Cr | -5.45 | 0.33 | 0.00 | -5.30 | 1.30 | -3.51 | ||
0.78 | 161 Cr | 18.04 | 0.41 | 0.00 | 2.28 | 1.66 | 1.41 | ||
142.00 | 151 Cr | 37.82 | 2.77 | 0.73 | 7.30 | 9.54 | 6.14 | ||
138.50 | 142 Cr | -218.18 | 14.55 | 0.00 | -5.50 | -5.50 | -11.23 | ||
| Median: 5 Co. | — | 36.29 | 161 Cr | -5.45 | 0.61 | 0.00 | -0.60 | 1.30 | -1.68 |
